Section 13-3301 – Definitions
(a) In this subtitle the following words have the meanings indicated. (b) “Academic research representative” means an employee or agent of an institution of higher education, a related medical facility, or an affiliated biomedical research firm that filed a registration with the Commission under § 13–3304.1 of this subtitle who is authorized to purchase medical cannabis for […]
Section 13-3301.1 – Legislative Intent
The General Assembly intends that the programs implemented in accordance with this subtitle yield a successful but consumer–friendly medical cannabis industry in the State to provide patients affordable and adequate access to medical cannabis.
Section 13-3302 – Commission Established; Purpose and Duties
(a) There is a Natalie M. LaPrade Medical Cannabis Commission. (b) The Commission is an independent commission that functions within the Department. (c) The purpose of the Commission is to develop policies, procedures, guidelines, and regulations to implement programs to make medical cannabis available to qualifying patients in a safe and effective manner. (d) (1) The Commission shall develop identification […]
Section 13-3303 – Membership
(a) The Commission consists of the following 13 members: (1) The Secretary of Health, or the Secretary’s designee; (2) The following 5 members, appointed by the Governor with the advice and consent of the Senate: (i) Two licensed noncertified providers who are: 1. Physicians; 2. Dentists; 3. Podiatrists; 4. Nurse practitioners; 5. Nurse midwives; or 6. Physician assistants; (ii) One nurse or other health care provider […]